BACKGROUND: Obesity is associated with decreased insulin sensitivity, atherogenic dyslipidemia and hypertension, but clinical studies have also identified a "metabolically healthy" obese phenotype. OBJECTIVE: To compare the characteristics of so-called "metabolically healthy" obese (MHO), normal weight subjects (MHNW) and obese with insulin resistance in a nationally representative sample in the United States. DESIGN, SETTING AND PARTICIPANTS: Insulin resistance was defined by a homeostatic model assessment (HOMA) value in the upper tertile for the entire NHANES cohort. "Metabolic health" was defined as the absence of diabetes, insulin resistance, metabolic syndrome, and lipid-lowering therapy. The study evaluated the 314 MHO, 1173 MHNW and 843 insulin-resistant obese from among the 6485 non-diabetic, nno-pregnant adults aged 20-79 years, who participated to the United States National Health and Nutrition Examination Survey, 1999-2004. MAIN OUTCOME MEASURES: Demographic, metabolic, nutrition and physical activity features. RESULTS: MHO and MHNW groups were similar regarding age, and fasting glucose and triglyceride levels. MHO had higher insulin (P<0.0001), insulin resistance as measured with the homeostatic model (p<0.0001), non-HDL cholesterol (P=0.002 in females and P=0.049 in males) and C-reactive protein levels (P<0.0001 in females and P=0.038 in males), and lower high-density lipoprotein cholesterol (HDL) levels (P<0.002). In addition, MHO females had higher low-density lipoprotein (LDL) cholesterol levels (P=0.012) and systolic blood pressure (P=0.02), and lower intake of dietary fiber (P=0.0009) and levels of physical activity (p=0.002). Triglycerides levels were normal in the MHO group. CONCLUSIONS: "Metabolically healthy" obese people have multiple dysmetabolic changes that may signal increased risk for coronary artery disease.
BACKGROUND:Obesity is associated with decreased insulin sensitivity, atherogenic dyslipidemia and hypertension, but clinical studies have also identified a "metabolically healthy" obese phenotype. OBJECTIVE: To compare the characteristics of so-called "metabolically healthy" obese (MHO), normal weight subjects (MHNW) and obese with insulin resistance in a nationally representative sample in the United States. DESIGN, SETTING AND PARTICIPANTS: Insulin resistance was defined by a homeostatic model assessment (HOMA) value in the upper tertile for the entire NHANES cohort. "Metabolic health" was defined as the absence of diabetes, insulin resistance, metabolic syndrome, and lipid-lowering therapy. The study evaluated the 314 MHO, 1173 MHNW and 843 insulin-resistant obese from among the 6485 non-diabetic, nno-pregnant adults aged 20-79 years, who participated to the United States National Health and Nutrition Examination Survey, 1999-2004. MAIN OUTCOME MEASURES: Demographic, metabolic, nutrition and physical activity features. RESULTS: MHO and MHNW groups were similar regarding age, and fasting glucose and triglyceride levels. MHO had higher insulin (P<0.0001), insulin resistance as measured with the homeostatic model (p<0.0001), non-HDL cholesterol (P=0.002 in females and P=0.049 in males) and C-reactive protein levels (P<0.0001 in females and P=0.038 in males), and lower high-density lipoprotein cholesterol (HDL) levels (P<0.002). In addition, MHO females had higher low-density lipoprotein (LDL) cholesterol levels (P=0.012) and systolic blood pressure (P=0.02), and lower intake of dietary fiber (P=0.0009) and levels of physical activity (p=0.002). Triglycerides levels were normal in the MHO group. CONCLUSIONS: "Metabolically healthy" obesepeople have multiple dysmetabolic changes that may signal increased risk for coronary artery disease.
Authors: James B Meigs; Martin K Rutter; Lisa M Sullivan; Caroline S Fox; Ralph B D'Agostino; Peter W F Wilson Journal: Diabetes Care Date: 2007-01-26 Impact factor: 19.112
Authors: Martin K Rutter; Peter W F Wilson; Lisa M Sullivan; Caroline S Fox; Ralph B D'Agostino; James B Meigs Journal: Circulation Date: 2008-02-04 Impact factor: 29.690
Authors: Petra Schnell-Inderst; Ruth Schwarzer; Alexander Göhler; Norma Grandi; Kristin Grabein; Björn Stollenwerk; Jennifer Manne; Volker Klauss; Uwe Siebert; Jürgen Wasem Journal: Int J Technol Assess Health Care Date: 2010-01 Impact factor: 2.188
Authors: Chaoyang Li; Earl S Ford; Lisa C McGuire; Ali H Mokdad; Randie R Little; Gerald M Reaven Journal: Diabetes Care Date: 2006-11 Impact factor: 19.112
Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: Erardo Meriño-Ibarra; Ana Cenarro; Paula Martín; Angel Luis García-Otín; Jesús Goicoechea; Ana Guallar; Luisa Calvo; Fernando Civeira Journal: Med Clin (Barc) Date: 2007-02-10 Impact factor: 1.725
Authors: K H Pietiläinen; M Korkeila; L H Bogl; K R Westerterp; H Yki-Järvinen; J Kaprio; A Rissanen Journal: Int J Obes (Lond) Date: 2009-12-15 Impact factor: 5.095
Authors: Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers Journal: Arch Intern Med Date: 2008-08-11
Authors: Maria de Fátima Haueisen Sander Diniz; Alline Maria Rezende Beleigoli; Antônio Luiz P Ribeiro; Pedro Guatimosim Vidigal; Isabela M Bensenor; Paulo A Lotufo; Bruce B Duncan; Maria Inês Schmidt; Sandhi Maria Barreto Journal: Medicine (Baltimore) Date: 2016-07 Impact factor: 1.889
Authors: Catherine M Phillips; Christina Dillon; Janas M Harrington; Vera J C McCarthy; Patricia M Kearney; Anthony P Fitzgerald; Ivan J Perry Journal: PLoS One Date: 2013-10-17 Impact factor: 3.240